Glenmark Pharmaceuticals Ltd., a research-led, integrated global pharmaceutical company, announced that it has entered into a definitive agreement with Dr. Reddy’s Laboratories Ltd. to divest its brand Momat Rino (for Russia, Kazakhstan and Uzbekistan), Momat Rino Advance (for Russia), Momat A (for Kazakhstan and Uzbekistan), Glenspray and Glenspray Active (for Ukraine), along with rights to…
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the appointment of Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization for a period of five years with effect from 14th August, 2020. Bhattacharjee comes with over 30 years of global experience in leading Generics, Specialty and OTC Pharma, Medical Devices, and…